Skip Navigation

Lupus Research Alliance

MD

Driving Progress in Lupus Research: Highlights from the Lupus Research Alliance 2025 Forum for Discovery

December 9, 2025

LRA’s annual meeting brings together global leaders to accelerate breakthroughs in lupus The 2025 Lupus Research Alliance (LRA) Forum for...

Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus

2025 Targeted Research Program on Engineered Cell Therapies for Lupus (TRP-ECT) Awardees

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on...

Highlights from ACR Convergence 2024: Groundbreaking LRA-Funded Research and Innovative Therapies

December 5, 2024

The Lupus Research Alliance (LRA) is proud to showcase the groundbreaking work of its funded researchers presented at the...

Celebrating Native American Heritage Month: Meet Dr. Kent Kwoh, A Champion for Health Equity

November 14, 2024

During Native American Heritage Month, we celebrate a dedicated champion of health equity. As Chief of Rheumatology and Director...

Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy

The Lupus Research Alliance (LRA) announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The...

Recent Discoveries Shedding Light on Why Women Are at a Greater Risk for Lupus

Lupus is a complex autoimmune disease affecting millions worldwide with a staggering gender imbalance -- about 9 of 10...

Lupus Research Alliance Announces 2022 Dr. William E. Paul Distinguished Innovator Awards Investigating Harmful Immune T Cells

NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the...

LRA-Funded Researchers Presented Cutting Edge Methods and Discoveries at the Annual Rheumatology Meeting

November, 2022 The Lupus Research Alliance (LRA) aims to support the best science to prevent, treat and cure lupus. This year...

Overcoming the Uncertainties of Living with Chronic Diseases like Lupus

July 21, 2022 Interview with Michael D. Lockshin, MD, MACR Director Emeritus, Barbara Volcker Center for Women and Rheumatic Disease and...

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY....

Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment

November 3, 2020 There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by...

The Lupus Research Alliance Presents 2020 Lupus Insight Prize Recipient – Dr. Jane Salmon

New York, NY. September 25, 2020 -- The Lupus Research Alliance presented its 2020 Lupus Insight Prize to Jane...